Biotronik SE & Co KG has launched the Reliaty pacing system analyzer, in the Europe, after receiving CE approval and successful pre-market evaluation.
The pacing system analyzer (PSA) is used during an implantation of implantable pacemakers, implantable cardioverter-defibrillators (ICDs) and Cardiac Resynchronization Therapy (CRT) systems to ensure adequate lead placement, maintenance of basic cardiac functions, and to evaluate pacing parameters for customized device programming.
The new intuitive user interface and option for connecting to a larger external screen allows for quick and easy testing when time is of the essence, supporting safe and accurate measurements.
Reliaty also features an additional test channel that allows for testing of up three implanted cardiac leads to more easily accommodate CRT cases.
It is battery powered to last for more than 12 hours of service daily, and additionally offers a universal stationary power cord that can be used worldwide and the measurement data can be exported from the PSA to a memory stick or printed via Bluetooth.
Biotronik Cardiac Rhythm Management Global Marketing and Sales vice president Marlou Janssen said Reliaty is part of a completely new external device portfolio from Biotronik.
"Together with the new external pacemaker Reocor and the upcoming new programmer Renamic, Biotronik is setting new standards in offering the highest quality portfolio of external CRM devices," Janssen said.